Correlation Between Syros Pharmaceuticals and NanoString Technologies

Can any of the company-specific risk be diversified away by investing in both Syros Pharmaceuticals and NanoString Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syros Pharmaceuticals and NanoString Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Syros Pharmaceuticals and NanoString Technologies, you can compare the effects of market volatilities on Syros Pharmaceuticals and NanoString Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syros Pharmaceuticals with a short position of NanoString Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syros Pharmaceuticals and NanoString Technologies.

Diversification Opportunities for Syros Pharmaceuticals and NanoString Technologies

0.09

Correlation Coefficient

Syros Pharmaceuticals  NanoString Technologies

Significant diversification

The 3 months correlation between Syros and NanoString is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Syros Pharmaceuticals and NanoString Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NanoString Technologies and Syros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syros Pharmaceuticals are associated (or correlated) with NanoString Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NanoString Technologies has no effect on the direction of Syros Pharmaceuticals i.e., Syros Pharmaceuticals and NanoString Technologies go up and down completely randomly.

Pair Corralation between Syros Pharmaceuticals and NanoString Technologies

If you would invest  411.00  in NanoString Technologies on September 3, 2024 and sell it today you would earn a total of  0.00  from holding NanoString Technologies or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Syros Pharmaceuticals  vs.  NanoString Technologies

Syros Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Syros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

NanoString Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NanoString Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, NanoString Technologies is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Syros Pharmaceuticals and NanoString Technologies

The main advantage of trading using opposite Syros Pharmaceuticals and NanoString Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syros Pharmaceuticals position performs unexpectedly, NanoString Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NanoString Technologies will offset losses from the drop in NanoString Technologies' long position.

The idea behind Syros Pharmaceuticals and NanoString Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.